Search - tctmd.com

Displaying 221 - 236 of 236

Sort: Relevancy | Date

News Daily News

Carotid Stenting Shows Steady Improvement in Patients at High Surgical Risk

Caitlin E. Cox

March 21, 2012

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

December 07, 2011

News Industry News

Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice

November 07, 2011

News Industry News

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

October 27, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

News Daily News

Conflicts of Interest Common in ACC-AHA Practice Guidelines

Caitlin E. Cox

March 30, 2011

CME

The Role of Atrial Shunts in the Treatment of HFpEF

CME

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

BIO

Sanjay Kaul, MD

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Advertisement

Carotid Stenting Shows Steady Improvement in Patients at High Surgical Risk

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

First DES for Above-the-Knee Vascular Disease on the Horizon

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Ticagrelor Gains FDA Approval for Use in ACS

Canada Approves Ticagrelor in ACS Patients

Conflicts of Interest Common in ACC-AHA Practice Guidelines

The Role of Atrial Shunts in the Treatment of HFpEF

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Sanjay Kaul, MD

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content